We are live on ! Find out more
HBIO icon

Harvard Bioscience
HBIO

68 hedge funds and large institutions have $66M invested in Harvard Bioscience in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

9% more capital invested

Capital invested by funds: $60.6M → $66M (+$5.45M)

6.3% more ownership

Funds ownership: 0% → 6.3% (+6.3%)

1% less funds holding

Funds holding: 69 → 68 (-1)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
68
Holders Change
-1
Holders Change %
-1.45%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
27
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GPC
Glacier Peak Capital
Washington
+$1.28M
2
GIM
Granahan Investment Management
Massachusetts
+$551K
3
IAM
ICM Asset Management
Washington
+$378K
4
FP
Foundry Partners
Minnesota
+$309K
5
BCM
Bridgeway Capital Management
Texas
+$293K

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$2.85M
2
PCMI
Paradigm Capital Management Inc
New York
-$1.58M
3
HA
Heartland Advisors
Wisconsin
-$763K
4
MOACM
Mutual of America Capital Management
New York
-$680K
5
RA
Royce & Associates
New York
-$375K
Name Holding Trade Value Shares
Change 		Change in
Stake
EGA
26
Eagle Global Advisors
Texas
$477K – – –
IAM
27
ICM Asset Management
Washington
$453K +$378K +14,866 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$445K +$1.35K +53 +0.4%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$425K – – –
First Manhattan
30
First Manhattan
New York
$399K +$170K +6,700 +105%
BFA
31
BlackRock Fund Advisors
California
$319K +$18.4K +723 +7%
SIM
32
Spark Investment Management
New York
$316K +$509 +20 +0.2%
Bank of America
33
Bank of America
North Carolina
$305K +$331 +13 +0.1%
AG
34
Algert Global
California
$295K +$122K +4,803 +99%
Northern Trust
35
Northern Trust
Illinois
$240K +$7.35K +289 +4%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$235K +$3.13K +123 +2%
AIM
37
Acrospire Investment Management
Illinois
$201K +$136K +5,332 +420%
Invesco
38
Invesco
Georgia
$174K -$2.11K -83 -1%
Morgan Stanley
39
Morgan Stanley
New York
$169K +$87.3K +3,434 +164%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$166K +$138K +5,431 New
TC
41
TFS Capital
Pennsylvania
$165K +$55.1K +2,165 +67%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$113K -$5.67K -223 -6%
SKK
43
Shepherd Kaplan Krochuk
Massachusetts
$104K +$87.1K +3,425 New
Goldman Sachs
44
Goldman Sachs
New York
$96K +$40.7K +1,601 +103%
Millennium Management
45
Millennium Management
New York
$88K -$43.6K -1,713 -37%
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$86K – – –
Two Sigma Advisers
47
Two Sigma Advisers
New York
$83K -$254 -10 -0.4%
BG
48
BlackRock Group
United Kingdom
$81K – – –
Russell Investments Group
49
Russell Investments Group
United Kingdom
$76K +$66.5K +2,616 New
Charles Schwab
50
Charles Schwab
California
$59K – – –
1
2
3 4

HBIO Hedge Fund Activity: Q4 2016 in Review

68 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q4 2016, worth a combined $66M — up 9% from $60.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HBIO positions and 7 closed out — a net gain of 1 holder — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Glacier Peak Capital, adding an estimated $1.28M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $2.85M sold.

  • 68 institutional investors held Harvard Bioscience (HBIO) as of Q4 2016, down from 69 in Q3 2016.
  • Funds reported $66M of Harvard Bioscience stock for Q4 2016, up 9% quarter-over-quarter.
  • 8 funds opened new Harvard Bioscience positions in Q4 2016 and 7 closed out, a net change of +1 holder.
  • The largest Harvard Bioscience buyer in Q4 2016 was Glacier Peak Capital, an estimated $1.28M added.
  • The largest Harvard Bioscience seller in Q4 2016 was Polar Asset Management Partners, an estimated $2.85M sold.

Based on aggregated 13F filings for Q4 2016.